Study: Use Of CBD Products For Health Becoming Widespread

CALIFORNIA: The use of cannabidiol products for the treatment of either a specific health condition or for general well-being is becoming prevalent among the general public, according to survey data published in the journal Cannabis and Cannabinoid Research.

Researchers at San Diego State University and at the National University of Natural Medicine in Portland, Oregon surveyed a self-selected cohort of 2,409 respondents with regard to their use of CBD products. Respondents typically ranged between 55 and 74 years of age.

Almost 62 percent of respondents reported using CBD for the purposes of treating a specific medical condition. The top three most commonly cited medical conditions were pain, anxiety, and depression. Almost 36 percent of subjects reported that CBD treats their medical conditions “very well by itself,” while only 4.3 percent reported the substance to be largely ineffective.

Authors concluded: “The use of CBD among individuals for both specific health conditions and general health and well-being is widespread. … CBD is being used as a specific therapy for a number of diverse medical conditions – particularly pain and inflammatory disorders, in addition to anxiety, depression, and sleep disorders. A large percentage of respondents indicate that CBD treats their condition(s) effectively in the absence of conventional medicine and with non-serious adverse effects. These data provide a compelling rationale for further research to better understand the therapeutic potential of CBD in treating chronic pain, anxiety, depression, sleep disorders, and other medical conditions.”


For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “A cross-sectional study of cannabidiol users,” appears in Cannabis and Cannabinoid Research.

Patients Frequently Turning To Cannabis To Treat Symptoms Of Sickle Cell Disease

CONNECTICUT: Medical cannabis use is relatively common among patients with sickle cell disease, according to survey data published in the journal Cannabis and Cannabinoid Research.

Investigators at Yale University conducted an anonymous questionnaire among 58 patients with the disease. Forty-two percent of respondents reported having used cannabis within the past two years, and 31 percent reported having used it within the past month. Most respondents said that said they did so for therapeutic purposes. Common symptoms of sickle cell disease include pain, fatigue, and swelling of the hands and feet.

Many respondents acknowledged that the use of cannabis “allowed for less use of pain medications” – a finding that is consistent with reports from other cohorts of chronic pain patients.

To date, the use of medicinal cannabis has not been evaluated in controlled settings for patients with sickle cell disease.

Authors concluded: “From our study as well as a few other reports, it appears that many adults with sickle cell disease use marijuana in the belief that it has medicinal benefits. … Thus, there is a strong rationale for the study of the medicinal properties of marijuana and/or its constituents in sickle cell disease.”


For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Marijuana use in adults living with sickle cell disease,” appears in Cannabis and Cannabinoid Research.